Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/164730
Xyloglucan, Hibiscus and Propolis for the prevention of Urinary Tract Infections: results of in vitro studies
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Aim: To assess the properties of a medical device containing xyloglucan, propolis and hibiscus to create a bioprotective barrier to avoid the contact of uropathogenic Escherichia coli strains on cell walls in models of intestinal (CacoGoblet) and uroepithelial (RWPE-1) cells (derived from normal human prostate epithelium). Materials & methods: Two uropathogenic E. coli strains (expressing type 1 fimbriae and P fimbriae) were used to assess, by electronic microscopy and ELISA, the barrier properties of the medical device. The antimicrobial activity was assessed in broth dilution assays. Results: The three components (xyloglucan, propolis and hibiscus) did not alter E. coli cell integrity in intestinal and uroepithelial cell models and were devoid of antibacterial activity. The three components avoided bacterial contact in both cell monolayers. Conclusion: The nonpharmacological barrier properties of xyloglucan, propolis and hibiscus confirm the role of the medical device for the management of urinary tract infections.
Matèries (anglès)
Citació
Citació
FRAILE, Benito, ALCOVER, Javier, ROYUELA, Mar, RODRÍGUEZ, David, CHAVES, Concepción, PALACIOS, Ricardo, PIQUÉ I CLUSELLA, Núria. Xyloglucan, Hibiscus and Propolis for the prevention of Urinary Tract Infections: results of in vitro studies. _Future Microbiology_. 2017. Vol. 12, núm. 721-731. [consulta: 9 de gener de 2026]. ISSN: 1746-0913. [Disponible a: https://hdl.handle.net/2445/164730]